New Research Reports For Microsoft, Caterpillar & Thermo Fisher

 | Oct 13, 2016 01:06AM ET

Thursday, October 13, 2016

We are featuring 16 new research reports in today's Research Daily, including analyst-written reports on buy-rated Caterpillar (NYSE:CAT), Microsoft (NASDAQ:MSFT) and Thermo Fisher (TMO).

Caterpillar shares have struggled over the last few years as a result of the commodity bust and weak global spending on infrastructure and construction. But after bottoming earlier this year, the stock has had an impressive run up (up more than 28% year-to-date), with improving outlook for construction activities and management efforts to improve efficiencies and squeeze costs out of operations finally getting acknowledged. While the outlook for mining continues to be problematic, the construction has started showing signs of life, as recent data from the Asia Pacific region show. This is starting to show up in rising EPS estimates for this buy-rated stock. (You can )

Microsoft shares have lagged the Tech sector and the broader market this year (the stock is up about 3% year-to-date), given continued headwinds in the PC space that has weighed on the Windows 10 adoption rates. But the company's efforts to reorganize and reposition its businesses hold long-term promise. Microsoft's cloud opportunity particularly stands out, with the company appearing to be emerging as a leader in this fast-growing space, alongside Amazon (NASDAQ:AMZN), Google's parent Alphabet (NASDAQ:GOOGL) and others. The Zacks analyst also likes buy-rated Microsoft's enterprise strength, the Office 365 subscription model, Azure and promising new products in the augmented and virtual reality space. (You can )

Thermo Fisher shares have outperformed the broader medical sector (up more than 8% year-to-date), with the recently completed FEI Company acquisition expected to significantly facilitate the company’s performance in life-science research. The FEI acquisition followed the successful purchase and integration of Affimetrix that boosted the buy-rated Thermo Fisher's offerings in the fast-growing flow cytometry market. Fresh product launches, strong growth in emerging markets and an enhancement in the company’s customer value proposition are other positives. (You can )

Other noteworthy reports we are featuring today include Alcoa (NYSE:AA), Baxter (BAX) and PNC Financial (NYSE:PNC).

Today's Long-Term Buys & Sells
Today you can gain access to the best long-term trades unearthed by Zacks Research. These moves have double and triple-digit profit potential and are rarely available to the public. Starting now, you can look inside our stocks under $10, home run and value stock portfolios, plus more. Want a peek at this private information? Click here >>

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

You can find all of today's stock research reports >>

Sheraz Mian

Director of Research

Note: If you want an email notification each time Sheraz publishes a new article, please

Today's Must Read/h6

Featured Reports/h6

Alcoa missed earnings and sales estimates in Q3 as it faced pricing headwinds. While pricing remains a concern, Alcoa should gain from productivity actions and contract wins, per the Zacks analyst.

Stanley Black & Decker's acquisition of Newell Tools will prove earnings accretive from year one of deal-closing. Annual cost synergies of $80-$90 million will be realized by year three.

The covering analyst thinks Gibraltar Industries is poised to grow on the $25 million Nexus buyout and value-creating growth strategy.

The Zacks analyst believes that Principal Financial's exposure to low interest rate environment will continue to weigh on investment results, while rising expenses will raise concern.

The covering analyst thinks the proposed acquisition of American Capital by Ares Capital may enhance shareholders' value given the steady dividend and the fee waiver support offered by Ares Capital.

The Zacks analyst believes Edison boasts a solid financial position backed by strong cash generation capacity.

The covering analyst thinks PNC Financial's efforts to improve operational efficiencies will go a long way in supporting bottom line amid slow revenue growth.

New Upgrades/h6

The Zacks analyst believes that Windstream's plans to strengthen its fixed wireless networks services by upgrading it with millimeter wave radio technology bodes well for its expansion efforts

The covering analyst believes that Lincoln National's continuous efforts to change its business mix toward more Life products without long-term guarantees ensures higher profitability in long term.

The Zacks analyst believes that Baxter is gaining prominence with a series of notable developments that include the launch of NUMETA 13E in Europe and the strategic tie-up with Satellite Healthcare.

New Downgrades/h6

Rent-A-Center disappointed investors with its bleak preliminary guidance for third-quarter 2016. The company now expects Core U.S. same store sales to be down nearly 12% in the quarter.

The Zacks analyst thinks weaker capital spending, sluggish oil & gas markets with risks in retail refrigeration business will hurt Dover's results. The Wayne buyout related investigation is a worry.

The covering analyst thinks cost of compliance to stringent regulations and related penalties remain a major concern for PG&E Corp. Changes in environmental mandates might also hurt its performance.

Zacks Investment Research

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes